The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab ± ipilimumab in treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC) with and without high microsatellite instability (MSI-H): CheckMate-142 interim results.
 
Michael J. Overman
Consulting or Advisory Role - Merrimack; sirtex Medical
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche
 
Scott Kopetz
Consulting or Advisory Role - Agendia; Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merrimack; Roche; Sanofi; Sysmex; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex
 
Raymond S. McDermott
No Relationships to Disclose
 
Joseph Leach
Research Funding - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; EMD Serono; Halozyme; OncoMed
 
Sara Lonardi
Consulting or Advisory Role - Bayer
Speakers' Bureau - Roche
Research Funding - Sanofi
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Michael A. Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Boehringer Ingelheim; EMD Serono; Etubics; Genentech/Roche; Ipsen; Lexicon; Merrimack; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Novartis
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Jayesh Desai
Honoraria - Bayer; Merck Serono; Novartis
Consulting or Advisory Role - Amgen; Bayer; Bionomics; Circadian Technologies; Merck Serono; Novartis
Research Funding - GlaxoSmithKline; Novartis; Roche
 
Andrew Hill
Stock and Other Ownership Interests - Tasman Oncology
Research Funding - Tasman Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Michael D. Axelson
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Rebecca Anne Moss
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - Bayer
Consulting or Advisory Role - Taiho Pharmaceutical
 
Chen-Sheng Lin
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Monica Goldberg
No Relationships to Disclose
 
Thierry Andre
Honoraria - Amgen; Baxter; BAYER; Bristol-Myers Squibb; Lilly; Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Roche/Genentech